Xcovery Drug Patent Portfolio
Xcovery owns 1 orange book drug protected by 4 US patents Given below is the list of Xcovery's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10899744 | Crystalline form of compound suppressing protein kinase activity, and application thereof | 01 Jun, 2037 | Active |
| US9126947 | Substituted pyridazine carboxamide compounds | 29 Nov, 2031 | Active |
| US9296724 | Substituted pyridazinecarboxamides as kinase inhibitors | 18 Jun, 2029 | Active |
| US8551995 | Kinase inhibitor compounds | 09 Feb, 2029 | Active |
Xcovery's Family Patents
Xcovery Drug List
Given below is the complete list of Xcovery's drugs and the patents protecting them.
1. Ensacove
Ensacove is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10899744 | Crystalline form of compound suppressing protein kinase activity, and application thereof |
01 Jun, 2037
(12 years from now)
| Active |
| US9126947 | Substituted pyridazine carboxamide compounds |
29 Nov, 2031
(6 years from now)
| Active |
| US9296724 | Substituted pyridazinecarboxamides as kinase inhibitors |
18 Jun, 2029
(4 years from now)
| Active |
| US8551995 | Kinase inhibitor compounds |
09 Feb, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ensacove's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List